These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19641233)

  • 41. Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100.
    Tremblay CL; Kollmann C; Giguel F; Chou TC; Hirsch MS
    J Acquir Immune Defic Syndr; 2000 Oct; 25(2):99-102. PubMed ID: 11103038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design of highly potent HIV fusion inhibitors based on artificial peptide sequences.
    Shi W; Cai L; Lu L; Wang C; Wang K; Xu L; Zhang S; Han H; Jiang X; Zheng B; Jiang S; Liu K
    Chem Commun (Camb); 2012 Dec; 48(94):11579-81. PubMed ID: 23093045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
    Kazmierski WM; Kenakin TP; Gudmundsson KS
    Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.
    Wang C; Shi W; Cai L; Lu L; Yu F; Wang Q; Jiang X; Xu X; Wang K; Xu L; Jiang S; Liu K
    J Antimicrob Chemother; 2014 Jun; 69(6):1537-45. PubMed ID: 24500189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains.
    He Y; Cheng J; Lu H; Li J; Hu J; Qi Z; Liu Z; Jiang S; Dai Q
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16332-7. PubMed ID: 18852475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides.
    Sonza S; Johnson A; Tyssen D; Spelman T; Lewis GR; Paull JR; Tachedjian G
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3565-8. PubMed ID: 19528284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rational design of HIV-1 entry inhibitors.
    Debnath AK
    Methods Mol Biol; 2013; 993():185-204. PubMed ID: 23568472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.
    Hrin R; Montgomery DL; Wang F; Condra JH; An Z; Strohl WR; Bianchi E; Pessi A; Joyce JG; Wang YJ
    AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1537-44. PubMed ID: 19102685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baseline susceptibility of primary HIV-2 to entry inhibitors.
    Borrego P; Calado R; Marcelino JM; Bártolo I; Rocha C; Cavaco-Silva P; Doroana M; Antunes F; Maltez F; Caixas U; Barroso H; Taveira N
    Antivir Ther; 2012; 17(3):565-70. PubMed ID: 22293827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
    Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
    Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides.
    Gantlett KE; Weber JN; Sattentau QJ
    Antiviral Res; 2007 Sep; 75(3):188-97. PubMed ID: 17408760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte.
    Liu S; Jiang S; Wu Z; Lv L; Zhang J; Zhu Z; Wu S
    Life Sci; 2002 Aug; 71(15):1779-91. PubMed ID: 12151056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment.
    Lee-Huang S; Zhang L; Huang PL; Chang YT; Huang PL
    Biochem Biophys Res Commun; 2003 Aug; 307(4):1029-37. PubMed ID: 12878215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New anionic carbosilane dendrons functionalized with a DO3A ligand at the focal point for the prevention of HIV-1 infection.
    Moreno S; Sepúlveda-Crespo D; de la Mata FJ; Gómez R; Muñoz-Fernández MÁ
    Antiviral Res; 2017 Oct; 146():54-64. PubMed ID: 28827122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.
    Hauber I; Hohenberg H; Holstermann B; Hunstein W; Hauber J
    Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9033-8. PubMed ID: 19451623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density.
    Geuenich S; Goffinet C; Venzke S; Nolkemper S; Baumann I; Plinkert P; Reichling J; Keppler OT
    Retrovirology; 2008 Mar; 5():27. PubMed ID: 18355409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent suppression of HIV-1 cell attachment by Kudzu root extract.
    Mediouni S; Jablonski JA; Tsuda S; Richard A; Kessing C; Andrade MV; Biswas A; Even Y; Tellinghuisen T; Choe H; Cameron M; Stevenson M; Valente ST
    Retrovirology; 2018 Sep; 15(1):64. PubMed ID: 30236131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small Molecule HIV-1 Attachment Inhibitors: Discovery, Mode of Action and Structural Basis of Inhibition.
    Lai YT
    Viruses; 2021 May; 13(5):. PubMed ID: 34066522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis, and structure-activity relationship of a novel series of 2-aryl 5-(4-oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 entry inhibitors.
    Katritzky AR; Tala SR; Lu H; Vakulenko AV; Chen QY; Sivapackiam J; Pandya K; Jiang S; Debnath AK
    J Med Chem; 2009 Dec; 52(23):7631-9. PubMed ID: 19746983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide.
    Neurath AR; Strick N; Li YY; Debnath AK
    BMC Infect Dis; 2004 Oct; 4():41. PubMed ID: 15485580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.